Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Achilles Therapeutics (ACHL)
NASDAQ:ACHL
RESEARCH TOOLSreports
Achilles Therapeutics (ACHL) Stock Price & Analysis
114 Followers
ACHL Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.74 - $1.76
Previous Close$0.92
Volume61.01K
Average Volume (3M)642.14K
Market Cap
$37.80M
Enterprise Value-$89.12M
Total Cash (Recent Filing)$131.54M
Total Debt (Recent Filing)$4.62M
Price to Earnings (P/E)N/A
Beta0.92
Next Earnings
Aug 06, 2024EPS Estimate
-$0.44Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding41,082,948
10 Day Avg. Volume171,469
30 Day Avg. Volume642,141
Standard Deviation0.20
R-Squared0.10
Alpha-0.07
Financial Highlights & Ratios
Price to Book (P/B)0.26
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda2.50
Forecast
1Y Price Target
$4.00Price Target Upside334.78% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Achilles Therapeutics News
PremiumCompany Announcements
Achilles Therapeutics: Promising Q1 2024 Results
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
0.23% Mutual Funds
41.86% Other Institutional Investors
57.91% Public Companies and
Individual Investors
ACHL FAQ
What was Achilles Therapeutics’s price range in the past 12 months?
Achilles Therapeutics lowest stock price was $0.74 and its highest was $1.76 in the past 12 months.
What is Achilles Therapeutics’s market cap?
Currently, no data Available
When is Achilles Therapeutics’s upcoming earnings report date?
Achilles Therapeutics’s upcoming earnings report date is Aug 06, 2024 which is in 83 days.
How were Achilles Therapeutics’s earnings last quarter?
Currently, no data Available
Is Achilles Therapeutics overvalued?
According to Wall Street analysts Achilles Therapeutics’s price is currently Undervalued.
Does Achilles Therapeutics pay dividends?
Achilles Therapeutics does not currently pay dividends.
What is Achilles Therapeutics’s EPS estimate?
Achilles Therapeutics’s EPS estimate is -$0.44.
How many shares outstanding does Achilles Therapeutics have?
Achilles Therapeutics has 40,938,763 shares outstanding.
What happened to Achilles Therapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Achilles Therapeutics?
Among the largest hedge funds holding Achilles Therapeutics’s share is Baker Bros Advisors LP. It holds Achilles Therapeutics’s shares valued at 2M.
---
Achilles Therapeutics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$4.00 (334.78% Upside)
$4.00 (334.78% Upside)
Blogger Sentiment
Bullish
ACHL Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 454.4K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 9.3%
Last 30 Days ▼ 9.3%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-3.05%
12-Months-Change
Fundamentals
Return on Equity
-40.91%
Trailing 12-Months
Asset Growth
-29.81%
Trailing 12-Months
Company Description
Achilles Therapeutics
Achilles Therapeutics PLC is a biopharmaceutical company. It is developing novel cancer immunotherapies targeting clonal neoantigens. The company has two ongoing trials, the CHIRON trial in patients with advanced non-small cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.
---
ACHL Stock 12 Month Forecast
Average Price Target
$4.00
▲(334.78% Upside)
Technical Analysis
Best Analysts Covering ACHL
1 Year
1 Year Success Rate
2/11 ratings generated profit
1 Year Average Return
-46.22%
reiterated a buy rating last month
Copying Geulah Livshits's trades and holding each position for 1 Year would result in 18.18% of your transactions generating a profit, with an average return of -46.22% per trade.
---